Direct and indirect associations between dietary magnesium intake and breast cancer risk

[1]  G. Matullo,et al.  Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort , 2017, Scientific Reports.

[2]  A. Sahebkar,et al.  Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2017, Current pharmaceutical design.

[3]  J. Manson,et al.  The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[4]  M. Rodríguez-Moran,et al.  Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. , 2016, Magnesium research.

[5]  F. Nielsen,et al.  Data from Controlled Metabolic Ward Studies Provide Guidance for the Determination of Status Indicators and Dietary Requirements for Magnesium , 2016, Biological Trace Element Research.

[6]  S. Edge,et al.  Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study. , 2015, American journal of cancer research.

[7]  G. Peters,et al.  The Importance of Magnesium in the Human Body: A Systematic Literature Review. , 2016, Advances in clinical chemistry.

[8]  A. Eggen,et al.  Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival , 2016, Breast Cancer Research and Treatment.

[9]  B. Asegaonkar,et al.  C-Reactive Protein and Breast Cancer: New Insights from Old Molecule , 2015, International journal of breast cancer.

[10]  D. Greenwood,et al.  Circulating C-Reactive Protein and Breast Cancer Risk—Systematic Literature Review and Meta-analysis of Prospective Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[11]  C. Matthews,et al.  Epidemiologic studies of estrogen metabolism and breast cancer , 2015, Steroids.

[12]  Shaokai Zhang,et al.  C-reactive protein and risk of breast cancer: A systematic review and meta-analysis , 2015, Scientific Reports.

[13]  P. Ridker,et al.  Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[14]  E. Simpson,et al.  Estrogens, Obesity, Inflammation, and Breast Cancer—What Is the Link? , 2015, Seminars in Reproductive Medicine.

[15]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[16]  A. Cox,et al.  Obesity, inflammation, and the gut microbiota. , 2015, The lancet. Diabetes & endocrinology.

[17]  M. Kurzer,et al.  Estrogen metabolism and breast cancer. , 2015, Cancer letters.

[18]  Jie He,et al.  [Association between the level of high sensitivity C-reactive protein and risk of breast cancer among non-diabetic females: a prospective study in Kailuan group]. , 2014, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[19]  G. Pond,et al.  Prognostic Impact of C-Reactive Protein in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis , 2014, Oncology Research and Treatment.

[20]  C. Calhau,et al.  Estrogen Signaling in Metabolic Inflammation , 2014, Mediators of inflammation.

[21]  M. Haluzík,et al.  The role of adipose tissue immune cells in obesity and low-grade inflammation. , 2014, The Journal of endocrinology.

[22]  G. Lee,et al.  Dietary Magnesium Intake and Risk of Cancer: A Meta-Analysis of Epidemiologic Studies , 2014, Nutrition and cancer.

[23]  Tao Xi,et al.  C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.

[24]  C. Crowther,et al.  Magnesium supplementation in pregnancy. , 2014, The Cochrane database of systematic reviews.

[25]  C. Rotimi,et al.  High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum. , 2014, Clinical biochemistry.

[26]  F. Clavel-Chapelon,et al.  C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study , 2014, Cancer Causes & Control.

[27]  N. Stachenfeld.  Hormonal Changes During Menopause and the Impact on Fluid Regulation , 2014, Reproductive Sciences.

[28]  Daniel T. Fisher,et al.  The two faces of IL-6 in the tumor microenvironment. , 2014, Seminars in immunology.

[29]  K. He,et al.  Dietary Magnesium Intake is Inversely Associated with Serum C-reactive Protein Levels: Meta-analysis and Systematic Review , 2013, European journal of clinical nutrition.

[30]  K. He,et al.  Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review , 2014, European Journal of Clinical Nutrition.

[31]  S. Sinha,et al.  Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. , 2013, Cytokine & growth factor reviews.

[32]  A. Akaberi,et al.  Intimate Partner Violence in the Eastern Part of Iran: A Path Analysis of Risk Factors , 2013, Issues in mental health nursing.

[33]  P. Hojman,et al.  The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.

[34]  Jianhua Yang,et al.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer , 2013, Protein & Cell.

[35]  Yihui Fan,et al.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer , 2013, Protein & Cell.

[36]  Yurii B. Shvetsov,et al.  Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer , 2013, Cancer Prevention Research.

[37]  Shyamasree Ghosh,et al.  C-reactive protein and the biology of disease , 2013, Immunologic Research.

[38]  S. Ho,et al.  Choline and betaine intake is inversely associated with breast cancer risk: A two‐stage case‐control study in China , 2013, Cancer science.

[39]  A. Duda-Chodak,et al.  Magnesium: its role in nutrition and carcinogenesis. , 2013, Roczniki Panstwowego Zakladu Higieny.

[40]  L. Pan,et al.  Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[41]  Jinping Zhao,et al.  Serum C-reactive protein and risk of lung cancer: a case–control study , 2013, Medical Oncology.

[42]  G. Bochi,et al.  Assessment of Inflammatory and Oxidative Biomarkers in Obesity and Their Associations with Body Mass Index , 2013, Inflammation.

[43]  M. Irwin,et al.  Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study , 2012, Psychological Medicine.

[44]  Yaling Tang,et al.  Inflammation linking EMT and cancer stem cells. , 2012, Oral oncology.

[45]  Simon C Watkins,et al.  Obesity-induced tissue free radical generation: an in vivo immuno-spin trapping study. , 2012, Free radical biology & medicine.

[46]  I. Takei,et al.  [The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases]. , 2012, Rinsho byori. The Japanese journal of clinical pathology.

[47]  C. Weaver,et al.  Suboptimal magnesium status in the United States: are the health consequences underestimated? , 2012, Nutrition reviews.

[48]  M. Houston.  The Role of Magnesium in Hypertension and Cardiovascular Disease , 2011, Journal of clinical hypertension.

[49]  S. Castiglioni,et al.  Magnesium and cancer: a dangerous liason. , 2011, Magnesium research.

[50]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[51]  Hyun-Sook Kim,et al.  Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. , 2011, Nutrition.

[52]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[53]  M. Karin,et al.  NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.

[54]  L. Galland.  Diet and inflammation. , 2010, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[55]  Huawei Zeng,et al.  Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. , 2010, Magnesium research.

[56]  Brij B. Singh,et al.  Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer? , 2010, Medical hypotheses.

[57]  D. Jacobs,et al.  Magnesium Intake in Relation to Systemic Inflammation, Insulin Resistance, and the Incidence of Diabetes , 2010, Diabetes Care.

[58]  F. Nielsen,et al.  Magnesium, inflammation, and obesity in chronic disease. , 2010, Nutrition reviews.

[59]  S. Ho,et al.  Validity and reproducibility of a food frequency Questionnaire among Chinese women in Guangdong province. , 2009, Asia Pacific journal of clinical nutrition.

[60]  Ross J. Harris,et al.  Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis , 2009, Cancer Causes & Control.

[61]  J. Manson,et al.  C-reactive protein and risk of breast cancer. , 2007, Journal of the National Cancer Institute.

[62]  F. Nielsen,et al.  Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women. , 2007, Magnesium research.

[63]  F. Wolf,et al.  Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. , 2007, Archives of biochemistry and biophysics.

[64]  B. Gajewski,et al.  Non‐normal path analysis in the presence of measurement error and missing data: a Bayesian analysis of nursing homes' structure and outcomes , 2006, Statistics in medicine.

[65]  A. Tukiendorf,et al.  New data on ecological analysis of possible relationship between magnesium in drinking water and liver cancer. , 2004, Magnesium research.

[66]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[67]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[68]  B. Canaud,et al.  La CRP est-elle plus qu'un marqueur de l'inflammation ? , 2003 .

[69]  A. Meinders,et al.  C-reactive protein: history and revival. , 2002, European journal of internal medicine.

[70]  Bei-fan Zhou.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. , 2002, Biomedical and environmental sciences : BES.

[71]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[72]  Trong-Neng Wu,et al.  CALCIUM AND MAGNESIUM IN DRINKING WATER AND THE RISK OF DEATH FROM BREAST CANCER , 2000 .

[73]  Trong-Neng Wu,et al.  Calcium and magnesium in drinking water and the risk of death from breast cancer. , 2000, Journal of toxicology and environmental health. Part A.

[74]  N E Saris,et al.  Magnesium. An update on physiological, clinical and analytical aspects. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[75]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[76]  D. Tassinari,et al.  Serum and erythrocyte magnesium concentrations in solid tumours: relationship with stage of malignancy. , 1992, Magnesium research.

[77]  J. French,et al.  Magnesium: nature's physiologic calcium blocker. , 1984, American heart journal.

[78]  C. Mold,et al.  C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.